Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Capital Expenditures (2016 - 2025)

Cross Country Healthcare (CCRN) has disclosed Capital Expenditures for 16 consecutive years, with $2.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures fell 16.36% year-over-year to $2.1 million, compared with a TTM value of $8.2 million through Dec 2025, down 6.35%, and an annual FY2025 reading of $8.2 million, down 6.35% over the prior year.
  • Capital Expenditures was $2.1 million for Q4 2025 at Cross Country Healthcare, down from $2.2 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $4.0 million in Q2 2023 and bottomed at $1.1 million in Q3 2024.
  • Average Capital Expenditures over 5 years is $2.3 million, with a median of $2.2 million recorded in 2025.
  • The sharpest move saw Capital Expenditures soared 138.49% in 2021, then plummeted 67.18% in 2024.
  • Year by year, Capital Expenditures stood at $2.3 million in 2021, then dropped by 11.27% to $2.0 million in 2022, then surged by 42.12% to $2.9 million in 2023, then decreased by 11.97% to $2.5 million in 2024, then fell by 16.36% to $2.1 million in 2025.
  • Business Quant data shows Capital Expenditures for CCRN at $2.1 million in Q4 2025, $2.2 million in Q3 2025, and $2.0 million in Q2 2025.